TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04101045

Pathogenesis of the Cardiometabolic Risk in Youth With Type 1 Diabetes

Cause of deathStaffing, sites or logistics, also funding or business Automatic label, confidence 0.6, unverified. How labels are made.
“During the pandemic the funding agency stopped funding studies.”

The sponsor’s own words in the registry.

Life of this trial

20192020202120222023Registered2019-09-17Started2019-11-21Stopped2022-03-30

Vital statistics

Status
Terminated
Phase
Na
Sponsor
Yale University
Sponsor type
University, hospital or other
Conditions
Type 1 Diabetes; De Novo Lipogenesis
Interventions
Oral Glucose Tolerance Test
Participants
7
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.